메뉴 건너뛰기




Volumn 31, Issue 12, 2010, Pages 2222-2228

Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure

Author keywords

Ghrelin; GHSR 1a; Heart failure; Immunohistochemistry; Myocardium

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GHRELIN; GHRELIN RECEPTOR; GHRELIN RECEPTOR 1A; GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

EID: 78049483949     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.08.019     Document Type: Article
Times cited : (62)

References (24)
  • 1
    • 0142200403 scopus 로고    scopus 로고
    • Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin
    • I. Bedendi, G. Alloatti, A. Marcantoni, D. Malan, F. Catapano, and C. Ghé Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin Eur J Pharmacol 476 2003 87 95
    • (2003) Eur J Pharmacol , vol.476 , pp. 87-95
    • Bedendi, I.1    Alloatti, G.2    Marcantoni, A.3    Malan, D.4    Catapano, F.5    Ghé, C.6
  • 2
    • 0037013178 scopus 로고    scopus 로고
    • CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
    • V. Bodart, M. Febbraio, A. Demers, N. McNicoll, P. Pohankova, and A. Perreault CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart Circ Res 90 2002 844 849
    • (2002) Circ Res , vol.90 , pp. 844-849
    • Bodart, V.1    Febbraio, M.2    Demers, A.3    McNicoll, N.4    Pohankova, P.5    Perreault, A.6
  • 3
    • 0141923119 scopus 로고    scopus 로고
    • Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans
    • M. Enomoto, N. Nagaya, M. Uematsu, H. Okumura, E. Nakagawa, and F. Ono Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans Clin Sci (Lond) 105 2003 431 435
    • (2003) Clin Sci (Lond) , vol.105 , pp. 431-435
    • Enomoto, M.1    Nagaya, N.2    Uematsu, M.3    Okumura, H.4    Nakagawa, E.5    Ono, F.6
  • 4
    • 0242383502 scopus 로고    scopus 로고
    • Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart
    • S. Frascarelli, S. Ghelardoni, S. Ronca-Testoni, and R. Zucchi Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart Basic Res Cardiol 98 2003 401 405
    • (2003) Basic Res Cardiol , vol.98 , pp. 401-405
    • Frascarelli, S.1    Ghelardoni, S.2    Ronca-Testoni, S.3    Zucchi, R.4
  • 6
    • 70449656984 scopus 로고    scopus 로고
    • Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect
    • C.X. Huang, M.J. Yuan, H. Huang, G. Wu, Y. Liu, and S.B. Yu Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect Peptides 30 2009 2286 2291
    • (2009) Peptides , vol.30 , pp. 2286-2291
    • Huang, C.X.1    Yuan, M.J.2    Huang, H.3    Wu, G.4    Liu, Y.5    Yu, S.B.6
  • 8
    • 0036123510 scopus 로고    scopus 로고
    • Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines
    • P.L. Jeffery, A.C. Herington, and L.K. Chopin Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines J Endocrinol 172 2002 R7 11
    • (2002) J Endocrinol , vol.172 , pp. 7-11
    • Jeffery, P.L.1    Herington, A.C.2    Chopin, L.K.3
  • 9
    • 0033540056 scopus 로고    scopus 로고
    • Ghrelin is a growth-hormone-releasing acylated peptide from stomach
    • M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660
    • (1999) Nature , vol.402 , pp. 656-660
    • Kojima, M.1    Hosoda, H.2    Date, Y.3    Nakazato, M.4    Matsuo, H.5    Kangawa, K.6
  • 10
    • 77954591294 scopus 로고    scopus 로고
    • Ghrelin: More than endogenous growth hormone secretagogue
    • M. Kojima, and K. Kangawa Ghrelin: more than endogenous growth hormone secretagogue Ann N Y Acad Sci 1200 2010 140 148
    • (2010) Ann N y Acad Sci , vol.1200 , pp. 140-148
    • Kojima, M.1    Kangawa, K.2
  • 11
    • 33646231528 scopus 로고    scopus 로고
    • Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats
    • L. Li, L.K. Zhang, Y.Z. Pang, C.S. Pan, Y.F. Qi, and L. Chen Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats Acta Pharmacol Sin 27 2006 527 535
    • (2006) Acta Pharmacol Sin , vol.27 , pp. 527-535
    • Li, L.1    Zhang, L.K.2    Pang, Y.Z.3    Pan, C.S.4    Qi, Y.F.5    Chen, L.6
  • 13
    • 20844460120 scopus 로고    scopus 로고
    • Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure
    • N. Nagaya, J. Moriya, Y. Yasumura, M. Uematsu, F. Ono, and W. Shimizu Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure Circulation 110 2004 3674 3679
    • (2004) Circulation , vol.110 , pp. 3674-3679
    • Nagaya, N.1    Moriya, J.2    Yasumura, Y.3    Uematsu, M.4    Ono, F.5    Shimizu, W.6
  • 14
    • 0035908954 scopus 로고    scopus 로고
    • Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure
    • N. Nagaya, M. Uematsu, M. Kojima, Y. Ikeda, F. Yoshihara, and W. Shimizu Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure Circulation 104 2001 1430 1435
    • (2001) Circulation , vol.104 , pp. 1430-1435
    • Nagaya, N.1    Uematsu, M.2    Kojima, M.3    Ikeda, Y.4    Yoshihara, F.5    Shimizu, W.6
  • 15
    • 0037784049 scopus 로고    scopus 로고
    • Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure
    • N. Nagaya, and K. Kangawa Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure Regul Pept 114 2003 71 77
    • (2003) Regul Pept , vol.114 , pp. 71-77
    • Nagaya, N.1    Kangawa, K.2
  • 16
    • 0035940390 scopus 로고    scopus 로고
    • Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: Relationships between ghrelin and anabolic/catabolic factors
    • N. Nagaya, M. Uematsu, M. Kojima, Y. Date, M. Nakazato, and H. Okumura Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors Circulation 104 2001 2034 2038
    • (2001) Circulation , vol.104 , pp. 2034-2038
    • Nagaya, N.1    Uematsu, M.2    Kojima, M.3    Date, Y.4    Nakazato, M.5    Okumura, H.6
  • 18
    • 38949117904 scopus 로고    scopus 로고
    • Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors
    • S. Perez, L.J. Royo, A. Astudillo, D. Escudero, F. Alvarez, and A. Rodriguez Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors BMC Mol Biol 8 2007 114
    • (2007) BMC Mol Biol , vol.8 , pp. 114
    • Perez, S.1    Royo, L.J.2    Astudillo, A.3    Escudero, D.4    Alvarez, F.5    Rodriguez, A.6
  • 20
    • 77149180432 scopus 로고    scopus 로고
    • Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome
    • A. Rodriguez, J. Gomez-Ambrosi, V. Catalan, S. Becerril, N. Sainz, and M.J. Gil Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome J Hypertens 28 2010 560 567
    • (2010) J Hypertens , vol.28 , pp. 560-567
    • Rodriguez, A.1    Gomez-Ambrosi, J.2    Catalan, V.3    Becerril, S.4    Sainz, N.5    Gil, M.J.6
  • 21
    • 33744980877 scopus 로고    scopus 로고
    • Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels
    • J.B. Soares, A. Rocha-Sousa, P. Castro-Chaves, T. Henriques-Coelho, and A.F. Leite-Moreira Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels Peptides 27 2006 1616 1623
    • (2006) Peptides , vol.27 , pp. 1616-1623
    • Soares, J.B.1    Rocha-Sousa, A.2    Castro-Chaves, P.3    Henriques-Coelho, T.4    Leite-Moreira, A.F.5
  • 22
    • 77956552524 scopus 로고    scopus 로고
    • Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure
    • F. Weis, A. Beiras-Fernandez, R. Sodian, I. Kaczmarek, B. Reichart, and A. Beiras Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure J Mol Cell Cardiol 48 2010 1187 1193
    • (2010) J Mol Cell Cardiol , vol.48 , pp. 1187-1193
    • Weis, F.1    Beiras-Fernandez, A.2    Sodian, R.3    Kaczmarek, I.4    Reichart, B.5    Beiras, A.6
  • 23
    • 0036687932 scopus 로고    scopus 로고
    • Comparison of vasodilators in human internal mammary artery: Ghrelin is a potent physiological antagonist of endothelin-1
    • K.E. Wiley, and A.P. Davenport Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1 Br J Pharmacol 136 2002 1146 1152
    • (2002) Br J Pharmacol , vol.136 , pp. 1146-1152
    • Wiley, K.E.1    Davenport, A.P.2
  • 24
    • 25444519434 scopus 로고    scopus 로고
    • GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure
    • X.B. Xu, J.J. Pang, J.M. Cao, C. Ni, R.K. Xu, and X.Z. Peng GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure Am J Physiol Heart Circ Physiol 289 2005 H1643 H1651
    • (2005) Am J Physiol Heart Circ Physiol , vol.289
    • Xu, X.B.1    Pang, J.J.2    Cao, J.M.3    Ni, C.4    Xu, R.K.5    Peng, X.Z.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.